Key result
Interferon treatment caused a significantly greater enhancement of the HCV-specific T-cell response in patients infected with HCV genotype 2c compared with genotype 1b.
Why the study?
Does interferon treatment differentially modulate HCV-specific T-cell responses in patients infected with HCV genotype 1b versus genotype 2c?
Observational (n=16)
Does interferon treatment differentially modulate HCV-specific T-cell responses in patients infected with HCV genotype 1b versus genotype 2c?
Interferon treatment induces a significantly greater enhancement of the HCV-specific T-cell response in patients with HCV genotype 2c compared to genotype 1b, potentially explaining differences in treatment responsiveness.
Answers are grounded in this paper and cite their sources.
May explain variable interferon efficacy by genotype; leaves open prospective confirmation of T-cell mediation.
The viral genotype may influence the response to interferon (IFN) treatment in chronic hepatitis C virus (HCV) infection. To characterize potential mechanisms responsible for this effect, we assessed whether IFN modulation of HCV-specific T-cell responses differs in patients infected by different genotypes. The T-cell response to HCV core protein was sequentially analyzed before and during IFN treatment in two groups of patients chronically infected with HCV genotype 1b (eight patients) or 2c (eight patients). Overlapping 20 mer peptides corresponding to the amino acid sequence of the prevalent viral population identified in the serum of each patient were used for the analysis of the T-cell proliferative response to avoid possible problems caused by amino acid differences between infecting virus and HCV proteins used in vitro. Recombinant HCV core antigen was used in parallel. The level of viremia was monitored by competitive polymerase chain reaction (PCR). The T-cell response to HCV peptides and recombinant core protein detected throughout the follow-up was significantly more vigorous in genotype 2c- than in genotype 1b-infected patients. This difference was the result of a greater enhancement of the T-cell response caused by IFN treatment in genotype 2c- compared with genotype 1b-infected patients. The different IFN modulatory effect on T cells from genotype 1b- and genotype 2c-infected patients illustrates an aspect of the virus-host interaction, which may contribute toward the explanation of why different genotypes differ in responsiveness to IFN treatment.
No takes yet. Share an insight, caveat, or question.
Missale et al. (1997) conducted an observational in Chronic hepatitis C virus (HCV) infection (n=16). HCV genotype 2c vs. HCV genotype 1b was evaluated on T-cell response to HCV core protein. Interferon treatment caused a significantly greater enhancement of the HCV-specific T-cell response in patients infected with HCV genotype 2c compared with genotype 1b.
Synapse has enriched 10 related papers. Consider them for comparative context: